Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05849480
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2023-05-08
Brief Title:
A Study of CDX-1140 a CD40 Agonist in Combination With Capecitabine and Oxaliplatin CAPOX and Keytruda in Subjects With Biliary Tract Carcinoma BTC
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2040-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2042-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-08
First Submit QC Date:
May 8 2023
Study First Post Date:
2023-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-06-05
Last Update Post Date Type:
ACTUAL